Cancer-causing mutations disrupt coordinated, precise programs of gene expression that
govern cell growth and differentiation. Microarray-based gene-expression profiling (GEP) is …

Multiple myeloma is a plasma cell malignancy characterized by complex heterogeneous
cytogenetic abnormalities. The bone marrow microenvironment promotes multiple myeloma …

Multiple Myeloma (MM) is a haematological malignancy characterised by the clonal
expansion of plasma cells (PC s) within the bone marrow. Despite advances in therapy, MM …

Multiple myeloma (MM) is an incurable malignancy in majority of patients characterized by
clonal proliferation of plasma cells. To date, treatment is established based on general …

Multiple myeloma (MM) is a complex disease that is driven by numerous genetic and
epigenetic alterations. Comprehensive oncogenomic analysis indicates the presence of …

Multiple myeloma (MM) is a clonal plasma cell malignancy that develops primarily in the
bone marrow (BM), where reciprocal interactions with the BM niche foster MM cell survival …

Multiple myeloma is a treatable, but currently incurable, hematological malignancy of
plasma cells characterized by diverse and complex tumor genetics for which precision …

Multiple myeloma (MM) is a hematologic malignancy that is considered mostly incurable in
large part due to the inability of standard of care therapies to overcome refractory disease …

Simple Summary Multiple myeloma (MM) is the second most common hematological
neoplasia with a high incidence in elderly populations. The disease is characterized by a …

PURPOSE Multiple myeloma (MM) is accompanied by heterogeneous somatic alterations.
The overall goal of this study was to describe the genomic landscape of myeloma using …